The Trump administration has put a hold on 100% tariffs on pharmaceutical companies that haven’t established production facilities in the U.S., though officials maintain that new taxes are still in effect.
Recently, President Trump announced on his social media platform that starting October 1, 2025, there would be a 100% tariff on patented or branded medications.
This announcement prompted companies to scramble, preparing for a significant tax on imported goods in less than a week. However, supply chain experts were left pondering how exactly this policy would be put into action.
As the federal government faces a shutdown, there’s uncertainty about whether key federal employees are on the job to roll out these new regulations.
On Monday, the administration indicated that they would offer some incentives regarding enforcement.
“While we’re in talks with these companies, we need them to engage in negotiations, as they are crucial for the American public,” said Commerce Secretary Howard Lutnick.
Authorities also confirmed that extra tariffs are active under Section 232 of the Trade Expansion Act of 1962.
This year, the Commerce Department started a review of the national security implications of importing pharmaceuticals and their ingredients, and experts suggest that this investigation might bolster the importance of these tariffs.
Pfizer’s CEO, Albert Brula, mentioned on Monday that the company would adhere to Trump’s executive orders regarding the “most preferred country,” stating that they received a three-year grace period from the 232 tariffs.
Nonetheless, the White House has indicated that tariffs are still functioning, though the enforcement timeline remains unclear.
“As Secretary Lutnick explained in today’s Oval Office briefing, from October 1, the Trump administration will oversee the manufacturing and setup of tariffs for pharmaceutical companies that align with the president’s most preferred country and lower drug prices,” they noted.
“President Trump is genuinely dedicated to reducing drug costs for Americans and will not shy away from using tariffs to achieve that,” they added.
